Funding for this research was provided by:
Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (NA)
Text and Data Mining valid from 2018-05-21
Received: 1 March 2018
Accepted: 11 May 2018
First Online: 21 May 2018
Compliance with ethical standards
: ACL has no conflicts of interest to disclose. CA reports honoraria and advisory role fees from Genentech, BMS, and Eli Lilly, and research funding from Macrogenics to the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. TMB reports research funding from Daiichi Sankyo, Medpachto Inc., Incyte, Mirati Therapeutics, MedImmune, Abbvie, AstraZeneca, Leap Therapeutics, MabVax, Stemline Therapeutics, Merck, Eli Lilly, GSK, Novartis, Pfizer, Principa Biopharma, Genentech/Roche, Deciphera, Merrimack, Immunogen, Takeda, Ignyta, Calithera Biosciences, Kolltan Pharmaceuticals, Principa Biopharma, Peleton, Immunocore, Roche, Aileron Therapeutics, BMS, and Amgen to the Sarah Cannon Research Institute/Tennessee Oncology PLLC, Nashville, TN, USA. CBL reports travel/accommodation fees or expenses from Novartis and research funding form Takeda, Novartis, and Genentech to the University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. DH reports research funding from Takeda. R.B.C. reports consulting or advisory roles for Takeda, BMS, Kolltan, Cerulean Pharma Inc., and Constellation Pharmaceuticals, and research funding from Takeda. FS, HF, and ABD report stock ownership in and employment by Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. FS reports travel/accommodation fees or expenses from Takeda. DVF reports employment by Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, and patents or intellectual property interests with Phoenicia BioSciences. TKN and BJD are former employees of Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. A.D. reports consulting or advisory role fees from Abbvie and AstraZeneca, and research funding from Abbvie, EMD Serono, Genentech, Eli Lilly, Piqur, Taino, Vertex, and Takeda.
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the participating institutions and the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all individual participants included in the study.